Compound Summary
药名: | taxol |
别名: | Paclitaxel |
分子式: | C47H51NO14 |
Smiles: | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C |
成分: | HBIN045705 |
CAS_id: | 33069-62-4 |
TCMID_id: | 20795 |
PubChem_id: | 36314 |
植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
---|
TCMBANKHE006791 | 落羽杉 | |||||
TCMBANKHE005103 | Taxus wallichiana | 喜马拉雅红豆杉 | ||||
TCMBANKHE005116 | Taxus cuspidata | 紫杉 | To disinhibit urine and free channels, anticancer./Kidney disease, diabetes mellitus, carcinoma of ovary, carcinoma of mammary glands. | |||
TCMBANKHE005329 | Taxus chinensis | 红豆杉 | ||||
TCMBANKHE005439 | Taxus baccata | 浆果紫杉 | ||||
TCMBANKHE007481 | Cephalotaxus hainanensis [Syn. Cephalotaxus mannii ] | 海南粗榧 | Anticancer./Carcinoma. | |||
TCMBANKHE007832 | Taxus brevifolia | 短叶红豆杉 | ||||
TCMBANKHE008274 | Ta x u s m e d i a | 介质红豆杉 | ||||
TCMBANKHE006189 | Taxus sumatrana | 苏门答腊红豆杉;苏门达腊红豆杉 | ||||
TCMBANKHE007281 | Taxus yunnanensis | 云南红豆杉 | ||||
TCMBANKHE008411 | Ta xus ma i rei | 美丽红豆杉 | To disperse accumulation, expel roundworm./Food accumulation, ascariasis. |
疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
---|
TCMBANKDI000001 | Stomach Neoplasms | group | Digestive System Diseases; Neoplasms | 24129235 |
TCMBANKDI000002 | Hyperalgesia | phenotype | Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 21145656 |
TCMBANKDI000007 | melanoma | disease | Neoplasms | 24080340 |
TCMBANKDI000019 | Parkinson Disease | disease | Nervous System Diseases | 25332110 |
TCMBANKDI000047 | Neoplasm Metastasis | phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | 31779616 |
TCMBANKDI000048 | Neoplasms | group | Neoplasms | 30322956 |
TCMBANKDI000084 | Platelet aggregation | phenotype | - | 22936655 |
TCMBANKDI000088 | Lung Neoplasms | group | Neoplasms; Respiratory Tract Diseases | 31779616 |
TCMBANKDI002163 | Neoplasms, Experimental | phenotype | Neoplasms | 20890306 |
TCMBANKDI002740 | Uterine Cervical Neoplasm | disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 24853425 |
TCMBANKDI002987 | Respiratory Function Tests | phenotype | - | 21621341 |
TCMBANKDI003353 | Carcinogenesis | phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | 28589243 |
TCMBANKDI006869 | Necrosis | phenotype | Pathological Conditions, Signs and Symptoms | 28162276 |
TCMBANKDI012424 | Neoplasm Invasiveness | phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | 24853425 |
TCMBANKDI013453 | Proteinuria | phenotype | Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 21984124 |
TCMBANKDI013888 | Fibrosis | phenotype | Pathological Conditions, Signs and Symptoms | 21984124 |
TCMBANKDI014770 | Polyploidy | phenotype | Pathological Conditions, Signs and Symptoms | 21368834 |
TCMBANKDI015242 | Peripheral Nervous System Diseases | group | Nervous System Diseases | 23726937 |
TCMBANKDI015496 | Liver neoplasms | group | Digestive System Diseases; Neoplasms | 29748662 |
TCMBANKDI015697 | Carcinoma, Transitional Cell | disease | Neoplasms | 20682548 |
TCMBANKDI015964 | Lymphatic Metastasis | disease | Pathological Conditions, Signs and Symptoms; Neoplasms | 25827073 |
TCMBANKDI022179 | Longevity | phenotype | - | 26913604 |
TCMBANKDI022691 | Triple Negative Breast Neoplasms | disease | Neoplasms; Skin and Connective Tissue Diseases | 24667715 |
TCMBANKDI025125 | Smoking | phenotype | Behavior and Behavior Mechanisms | 21621341 |
TCMBANKDI026887 | ovarian neoplasm | disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 31623606 |
TCMBANKDI029899 | Lymphoma | group | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 21621341 |
TCMBANKDI031190 | Thrombosis | phenotype | Cardiovascular Diseases | 22936655 |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000053 | NFKB1 | CVID12; EBP-1; KBF1; NF-kB; NF-kB1; NF-kappa-B1; NF-kappaB; NF-kappabeta; NFKB-p105; NFKB-p50; NFkappaB | nuclear factor kappa B subunit 1 |
TCMBANKGE000149 | MAP3K12 | DLK; MEKK12; MUK; ZPK; ZPKP1 | mitogen-activated protein kinase kinase kinase 12 |
TCMBANKGE000150 | MIR192 | MIRN192; miR-192; miRNA192 | microRNA 192 |
TCMBANKGE000151 | UBE2C | UBCH10; dJ447F3.2 | ubiquitin conjugating enzyme E2 C |
TCMBANKGE000152 | RANBP10 | - | RAN binding protein 10 |
TCMBANKGE000153 | USP7 | HAUSP; TEF1 | ubiquitin specific peptidase 7 |
TCMBANKGE000154 | CCR2 | CC-CKR-2; CCR-2; CCR2A; CCR2B; CD192; CKR2; CKR2A; CKR2B; CMKBR2; MCP-1-R | C-C motif chemokine receptor 2 |
TCMBANKGE000155 | SPAG5 | DEEPEST; MAP126; hMAP126 | sperm associated antigen 5 |
TCMBANKGE000156 | Atat1 | 0610011P08Rik; 2610008K08Rik; 2610110G12Rik; 3110080J08Rik; MEC-17; Mec17; TAT | alpha tubulin acetyltransferase 1 |
TCMBANKGE000157 | PRC1 | ASE1 | protein regulator of cytokinesis 1 |
TCMBANKGE000158 | RHOA | ARH12; ARHA; EDFAOB; RHO12; RHOH12 | ras homolog family member A |
TCMBANKGE000159 | RHOH | ARHH; TTF | ras homolog family member H |
TCMBANKGE000175 | FBXW7 | AGO; CDC4; FBW6; FBW7; FBX30; FBXO30; FBXW6; SEL-10; SEL10; hAgo; hCdc4 | F-box and WD repeat domain containing 7 |
TCMBANKGE000238 | IL10 | CSIF; GVHDS; IL-10; IL10A; TGIF | interleukin 10 |
TCMBANKGE000274 | CCL2 | GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF | C-C motif chemokine ligand 2 |
TCMBANKGE000280 | VIM | - | vimentin |
TCMBANKGE000289 | EIF2AK3 | PEK; PERK; WRS | eukaryotic translation initiation factor 2 alpha kinase 3 |
TCMBANKGE000313 | JUN | AP-1; AP1; c-Jun; cJUN; p39 | Jun proto-oncogene, AP-1 transcription factor subunit |
TCMBANKGE000590 | ILK | HEL-S-28; ILK-1; ILK-2; P59; p59ILK | integrin linked kinase |
TCMBANKGE000635 | AURKA | AIK; ARK1; AURA; BTAK; PPP1R47; STK15; STK6; STK7 | aurora kinase A |
TCMBANKGE000990 | EGFR | ERBB; ERBB1; HER1; NISBD2; PIG61; mENA | epidermal growth factor receptor |
TCMBANKGE001051 | MAP2K7 | JNKK2; MAPKK7; MEK; MEK 7; MKK7; PRKMK7; SAPKK-4; SAPKK4 | mitogen-activated protein kinase kinase 7 |
TCMBANKGE001061 | CDK5 | LIS7; PSSALRE | cyclin dependent kinase 5 |
TCMBANKGE001062 | PLK1 | PLK; STPK13 | polo like kinase 1 |
TCMBANKGE001083 | MAP3K5 | ASK1; MAPKKK5; MEKK5 | mitogen-activated protein kinase kinase kinase 5 |
TCMBANKGE001085 | MAPK8 | JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c | mitogen-activated protein kinase 8 |
TCMBANKGE001096 | TLR4 | ARMD10; CD284; TLR-4; TOLL | toll like receptor 4 |
TCMBANKGE001102 | MIR21 | MIRN21; hsa-mir-21; miR-21; miRNA21 | microRNA 21 |
TCMBANKGE001106 | MTOR | FRAP; FRAP1; FRAP2; RAFT1; RAPT1; SKS | mechanistic target of rapamycin kinase |
TCMBANKGE001123 | CTNNB1 | CTNNB; EVR7; MRD19; NEDSDV; armadillo | catenin beta 1 |
TCMBANKGE001131 | CASP9 | APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56 | caspase 9 |
TCMBANKGE001132 | BAX | BCL2L4 | BCL2 associated X, apoptosis regulator |
TCMBANKGE001133 | PTK2 | FADK; FAK; FAK1; FRNK; PPP1R71; p125FAK; pp125FAK | protein tyrosine kinase 2 |
TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
TCMBANKGE001169 | BCL2L1 | BCL-XL/S; BCL2L; BCLX; Bcl-X; PPP1R52 | BCL2 like 1 |
TCMBANKGE001173 | MCL1 | BCL2L3; EAT; MCL1-ES; MCL1L; MCL1S; Mcl-1; TM; bcl2-L-3; mcl1/EAT | MCL1 apoptosis regulator, BCL2 family member |
TCMBANKGE001177 | TP53 | BCC7; BMFS5; LFS1; P53; TRP53 | tumor protein p53 |
TCMBANKGE001179 | SMAD2 | JV18; JV18-1; MADH2; MADR2; hMAD-2; hSMAD2 | SMAD family member 2 |
TCMBANKGE001180 | SMAD3 | HSPC193; HsT17436; JV15-2; LDS1C; LDS3; MADH3 | SMAD family member 3 |
TCMBANKGE001181 | TGFB1 | CED; DPD1; IBDIMDE; LAP; TGF-beta1; TGFB; TGFbeta | transforming growth factor beta 1 |
TCMBANKGE001200 | STMN1 | C1orf215; LAP18; Lag; OP18; PP17; PP19; PR22; SMN | stathmin 1 |
TCMBANKGE001203 | MAPK1 | ERK; ERK-2; ERK2; ERT1; MAPK2; P42MAPK; PRKM1; PRKM2; p38; p40; p41; p41mapk; p42-MAPK | mitogen-activated protein kinase 1 |